Ganli Pharmaceutical Industry (603087.SH) plans to introduce a restricted stock incentive plan in 2026.

Judgment Financial News APP News, Ganli Pharmaceutical (603087.SH) disclosed the 2026 Restricted Stock Incentive Plan (draft). The number of restricted stocks to be granted to the incentive objects in this incentive plan is 630,000 shares, accounting for approximately 0.1055% of the company's total share capital of 597 million shares on the announcement date of the draft incentive plan. The grant price of the restricted stocks is 27.8 yuan/share. There are a total of 20 incentive objects, including senior management personnel and core technical (business) backbone who are employed in the company (including subsidiaries) at the time of the announcement of the incentive plan.